fructose 2,6-diphosphate has been researched along with Alcoholic Liver Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de la Monte, SM; Derdak, Z; Lang, CH; Mark, NM; Tong, M; Villegas, KA; Wands, JR | 1 |
1 other study(ies) available for fructose 2,6-diphosphate and Alcoholic Liver Diseases
| Article | Year |
|---|---|
Activation of p53 enhances apoptosis and insulin resistance in a rat model of alcoholic liver disease.
Topics: Alanine Transaminase; Animals; Apoptosis; Apoptosis Regulatory Proteins; Caspase 3; Disease Models, Animal; DNA Damage; DNA, Mitochondrial; Fatty Liver, Alcoholic; Fructosediphosphates; Gluconeogenesis; Insulin Resistance; Liver Diseases, Alcoholic; Male; Oxidative Stress; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Rats; Rats, Inbred F344; Rats, Long-Evans; Rats, Sprague-Dawley; Signal Transduction; Species Specificity; Sterol Regulatory Element Binding Protein 1; Tumor Suppressor Protein p53 | 2011 |